Table 2.
Variable | Timepoint | n | Mean ± SD | Change Mean (95% CI) |
p-value vs. baseline |
---|---|---|---|---|---|
CAS | Baseline | 285 | 12.4 ± 3.0 | 0 | |
3 months | 177 | 7.7 ± 4.4 | -4.7 (-5.2, -4.1) | < 0.001 | |
6 months | 204 | 6.8 ± 4.5 | -5.5 (-6.0, -4.9) | < 0.001 | |
WSAS | Baseline | 267 | 21.3 ± 7.7 | 0 | |
3 months | 169 | 19.0 ± 9.0 | -2.7 (-3.9, -1.5) | < 0.001 | |
6 months | 203 | 18.3 ± 9.0 | -3.4 (-4.5, -2.3) | < 0.001 | |
GAD-7 | Baseline | 274 | 15.4 ± 4.0 | 0 | |
3 months | 172 | 13.4 ± 5.0 | -2.2 (-2.9, -1.5) | < 0.001 | |
6 months | 203 | 12.5 ± 5.5 | -3.0 (-3.7, -2.3) | < 0.001 | |
sHAI | Baseline | 269 | 23.2 ± 7.1 | 0 | |
3 months | 171 | 21.7 ± 8.5 | -1.8 (-2.6, -0.9) | < 0.001 | |
6 months | 203 | 19.7 ± 8.4 | -3.5 (-4.3, -2.7) | < 0.001 | |
PHQ-9 | Baseline | 268 | 15.6 ± 5.5 | 0 | |
3 months | 170 | 13.8 ± 6.4 | -1.5 (-2.3, -0.7) | < 0.001 | |
6 months | 203 | 13.4 ± 6.7 | -2.1 (-2.9, -1.4) | < 0.001 | |
OCI-R | Baseline | 264 | 30.4 ± 15.3 | 0 | |
3 months | 169 | 28.2 ± 16.8 | -1.5 (-3.2, 0.2) | 0.09 | |
6 months | 203 | 25.9 ± 15.5 | -4.1 (-5.7, -2.5) | < 0.001 | |
AUDIT-C | Baseline | 264 | 2.66 ± 2.97 | 0 | |
3 months | 173 | 2.48 ± 2.77 | 0.03 (-0.22, 0.28) | 0.81 | |
6 months | 204 | 2.41 ± 2.62 | 0.02 (-0.22, 0.25) | 0.88 | |
Variable | Timepoint | n | n (%) |
Odds Ratio (95% CI) |
p-value vs. baseline |
Drug use | Baseline | 264 | 24 (9.1%) | 1 | |
3 months | 173 | 12 (6.9%) | 0.61 (0.18, 2.04) | 0.42 | |
6 months | 204 | 20 (9.8%) | 1.62 (0.58, 4.52) | 0.35 |